What if one of the biggest problems in an aging brain is not just that cells “wear out,” but that they slowly forget who they are supposed to be?
That is essentially what a recent perspective in Nature Reviews Neurology argues, based on work led by Larissa Traxler, Jerome Mertens, Fred H. Gage, and colleagues.
Their central idea is simple but powerful. To a large extent, neurons and glial cells switch between temporary “states” to cope with stress, but in older brains these emergency states can get stuck, pushing cells toward a permanent loss of identity that looks a lot like neurodegeneration.
For readers worried about brain health, this emerging framework does not only explain why age is the biggest risk factor for Alzheimer’s and other neurodegenerative diseases. It also hints at concrete ways to keep our brains resilient for longer.
Cell state vs. cell fate: a crash course
Every cell in your body has a “fate” — a more or less fixed identity and long-term job description. For neurons, that fate might be “stay a glutamatergic excitatory neuron in the hippocampus and keep firing to support memory and learning.”
For glia, it might be “stay an oligodendrocyte that wraps axons with myelin so signals move quickly.” Fate is fairly stable: your brain does not randomly convert neurons into liver or skin cells.
But within that fixed fate, cells can adopt many “states.” A neuron can be in a rested state, a stressed state, an actively firing state, a “repair” state after injury, or even a “senescent-like” state where it stops dividing and changes its behavior to cope with damage.
These states are mostly reversible. Once the stress passes and the damage is repaired, the ideal outcome is that the cell returns to its baseline state while keeping the same identity.
The new framework says aging pushes brain cells to spend more and more time in maladaptive states. Instead of fully recovering, they hover in chronic stress modes. Over time, that drift can blur a cell’s identity and function, tilting the brain ecosystem toward inflammation, loss of connections, and eventually clinical disease.
Why stress responses go from helpful to harmful
On short timescales, stress responses are essential. When cells detect threats — such as oxidative stress, protein misfolding, viral infection, or DNA breaks — they tighten up quality control, slow down growth, and ramp up repair. In a young brain, this is a controlled emergency drill.
The problem in aging is not that these responses exist, but that they are activated too often, for too long, or in too many cells at once. The brain’s immune cells (microglia and astrocytes) can stay stuck in a pro-inflammatory, hypervigilant state.
Neurons can dial down synaptic activity, withdraw connections, and stop participating fully in circuits. What starts as a temporary coping strategy becomes a semi-permanent mode.
A recent review in the journal Cell Communication and Signaling sums up these “hallmarks of aging” at the molecular level: genomic instability, telomere shortening, epigenetic drift, mitochondrial dysfunction, impaired proteostasis, stem-cell exhaustion, and chronic inflammation. All of these show up in aging brain tissue.
Many of the same signals that drive senescence, such as mitochondrial dysfunction, chronic inflammation, and telomere shortening, are already familiar from studies of cancer and systemic aging, but in the brain they have added consequences: they change how circuits fire and how information is processed.
From reversible states to lost identity
The perspective by Traxler and colleagues argues that when stress-state programs are repeatedly activated, they can gradually overwrite parts of a cell’s identity program.
Say a neuron in the prefrontal cortex spends years oscillating between high metabolic stress (from vascular problems or diabetes), inflammatory signals (from nearby glia), and DNA damage (from oxidative stress and environmental toxins).
Its gene expression profile shifts. Genes that define its specialized subtype may be dialed down, while genes that support generic stress survival, inflammation, or cell-cycle re-entry are dialed up.
At some point, the cell may still be alive but no longer behaves like a finely tuned cortical neuron. It may lose synapses, misfire, or even start expressing markers normally seen in other cell types. In extreme cases, cells can attempt to re-enter the cell cycle — something mature neurons are not supposed to do — and end up dying instead.
The surrounding network then must redistribute workload, which can degrade cognition long before a person meets clinical criteria for dementia.
This gradual “fate erosion” can help explain why brain scans often detect widespread atrophy and connectivity loss years before dementia diagnosis. It also fits with data from induced pluripotent stem cell (iPSC) models, where neurons derived from older adults already show altered stress responses and synaptic function, even outside the aging body.
Why this framework matters for real people
We often talk about Alzheimer’s and Parkinson’s as if there were a clear dividing line between “normal aging” and “disease.” In reality, the biology seems more like a spectrum.
Many older adults show mixtures of pathologies — amyloid plaques, tau tangles, vascular damage, Lewy bodies — along with chronic inflammation and metabolic stress. The state-versus-fate framework helps connect these dots. It suggests that what we call a disease might be the end-stage of decades of accumulated cell-state mismanagement.
For example, consider two people with the same amount of amyloid in their brains. One develops dementia, the other does not. Why? One possibility is that in the resilient person, neurons and glia manage to activate stress states quickly, clear the damage, and then return to a healthy baseline identity.
In the vulnerable person, the same stress pushes cells into chronic, partially dysfunctional states that gradually erode their specialized roles.
This view also meshes with what population studies have been telling us for years: cardiovascular risk factors, diabetes, obesity, smoking, depression, and low physical activity all increase dementia risk. These conditions bombard brain cells with exactly the kinds of stress signals — from hypoxia to inflammation to hormonal imbalance — that promote maladaptive states.
Can we safely “reset” aging brain cells?
If aging is, in part, about cells getting stuck in the wrong states, one tempting idea is to “reset” them toward a more youthful state. This is where some of the most headline-grabbing aging research comes in: partial cellular reprogramming.
Scientists can take adult cells and, by turning on a small set of genes known as the Yamanaka factors (OCT4, SOX2, KLF4, and c-MYC, often abbreviated OSKM), rewind them all the way back to an embryonic-like pluripotent state.
That full reset erases cell identity completely — which is useful for making iPSCs in the lab, but obviously dangerous in a living brain.
Partial reprogramming is a more cautious strategy. Instead of keeping OSKM on long enough to erase identity, researchers apply them in short bursts, hoping to rejuvenate aspects of the cell’s epigenetic and metabolic profile without changing its basic fate. In mouse experiments, short pulses of the OSKM reprogramming factors have been shown to partially roll back some aging markers and, in one striking study, restore vision after glaucoma-like injury.
This is exciting, but it is not ready for the clinic. Turning on powerful developmental programs in mature neurons carries serious risks: cancer, unwanted cell divisions, and unpredictable changes in connectivity.
The Traxler perspective emphasizes that any future therapies will need to be extremely precise about which cells are targeted, when, and for how long — and will likely need to be combined with strategies that reduce ongoing stress signals in the brain’s environment.
Targeting states, supporting fate: gentler approaches
The good news is that we already know some lower-risk ways to influence cell states. Many familiar lifestyle and medical interventions seem to work, at least in part, by trimming back chronic stress programs and supporting the brain’s maintenance and repair systems.
- Sleep: Deep, consolidated sleep helps clear metabolic waste, recalibrate synaptic connections, and reset stress hormones. Chronic sleep deprivation pushes neurons and glia toward pro-inflammatory, energy-starved states.
- Physical activity: Regular aerobic exercise increases blood flow, promotes the birth of new neurons in the hippocampus, and boosts neurotrophic factors like BDNF. These changes support healthier cell states and more robust cognitive reserve.
- Nutrition: Diets high in ultra-processed foods, added sugars, and trans fats are associated with systemic inflammation and metabolic dysfunction. Patterns like the Mediterranean or MIND diets, rich in whole grains, vegetables, fruits, legumes, nuts, and healthy fats, appear to reduce dementia risk, possibly by improving vascular health and lowering chronic inflammation in the brain.
- Cardiometabolic health: Treating hypertension, diabetes, and high cholesterol is not just about the heart. Healthy blood vessels and stable glucose levels reduce the hypoxic and metabolic stress that push brain cells into maladaptive states.
- Mental and social engagement: Learning new skills, having meaningful social roles, and staying mentally active do not just “exercise” circuits. They may also help maintain identity programs by repeatedly reinforcing the specialized functions of neurons in memory, language, and executive networks.
None of these habits is a magic bullet, and they cannot fully override strong genetic risks. But they all influence the balance of stress and repair signals that determine whether cells spend most of their time in healthy, specialized states or slide into chronic, maladaptive ones.
What this means for the future of aging research
The “cell state vs cell fate” idea is partly conceptual, but it has practical implications for how scientists design experiments and how doctors might one day personalize prevention.
Instead of just measuring how many neurons die, researchers are increasingly mapping which state programs are turned on in surviving cells. Single-cell RNA sequencing and epigenetic profiling can reveal, for example, whether certain neuron subtypes in the hippocampus or prefrontal cortex are drifting toward inflammatory, senescent, or dedifferentiated states.
In the clinic, biomarkers that capture these shifts — from inflammatory cytokine patterns to brain-imaging signatures of network inefficiency — could help identify people whose brain cells are under chronic stress long before they show overt symptoms. That could open a window for interventions that nudge cells back toward healthier states.
Bottom line: aging brains are dynamic, not doomed
The emerging picture is not of an inevitable, one-way slide into deterioration, but of a complex, dynamic negotiation inside every aging brain. Cells are constantly sensing, adapting, and making trade-offs between survival and specialization.
When those trade-offs go badly — through unrelenting stress, cardiovascular and metabolic disease, or unlucky genetic and environmental hits — cells can lose their way, drifting into states that keep them alive but no longer fully themselves.
Understanding and measuring those states opens a more hopeful path. It suggests that protecting brain health is not only about preventing classic pathologies like amyloid plaques, but also about creating conditions — biologically, psychologically, and socially — that help brain cells remember who they are.
The perspective was published in Nature Reviews Neurology.
